Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.55 |
| ▸ | MMP2 | P08253 | 4/20 | 0.53 |
| ▸ | ALPI | P09923 | 1/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.52 |
| ▸ | XIAP | P98170 | 1/20 | 0.52 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | SCN4A | P35499 | 2/20 | 0.49 |
| ▸ | ANPEP | P15144 | 1/20 | 0.48 |
| ▸ | SRR | Q9GZT4 | 2/20 | 0.47 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.47 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.47 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.47 |
| ▸ | TACR1 | P25103 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Solriamfetol SCHEMBL42526 | 1.00 | PKM (0.56) | PKMCYP1A2CYP2D6SMN1; SMN2NPSR1 | |
| Solriamfetol SCHEMBL2739637 | 1.00 | PKM (0.56) | PKMCYP1A2CYP2D6SMN1; SMN2NPSR1 | |
| Solriamfetol SCHEMBL30929349 | 1.00 | PKM (0.56) | PKMCYP1A2CYP2D6SMN1; SMN2NPSR1 | |
| Solriamfetol SCHEMBL42525 | 1.00 | PKM (0.56) | PKMCYP1A2CYP2D6SMN1; SMN2NPSR1 | |
| Solriamfetol SCHEMBL8430382 | 0.98 | PKM (0.54) | PKMCYP1A2CYP2D6SMN1; SMN2NPSR1 | |
| Solriamfetol SCHEMBL28413501 | 0.98 | PKM (0.54) | PKMCYP1A2CYP2D6SMN1; SMN2NPSR1 | |
| Solriamfetol SCHEMBL4987496 | 0.98 | PKM (0.54) | PKMCYP1A2CYP2D6SMN1; SMN2NPSR1 | |
| Solriamfetol SCHEMBL8426383 | 0.98 | PKM (0.54) | PKMCYP1A2CYP2D6SMN1; SMN2NPSR1 | |
| Solriamfetol SCHEMBL30518836 | 0.97 | PKM (0.53) | PKMCYP1A2CYP2D6SMN1; SMN2NPSR1 | |
| Solriamfetol SCHEMBL30518840 | 0.95 | PKM (0.51) | PKMCYP1A2CYP2D6SMN1; SMN2NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4626417-A1 | METHODS AND COMPOSITIONS FOR IMPROVING DRIVING PERFORMANCE | AXSOME THERAPEUTICS (US) | 2025-10-08 | — | — | EP | disclosed |
| US-20250223281-A1 | ANTIDIABETIC COMPOUNDS AND COMPOSITIONS | REZUBIO PHARMACEUTICALS CO., LTD (CN) | 2025-07-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250223281-A1 | ANTIDIABETIC COMPOUNDS AND COMPOSITIONS | GPR119, GLP1R, GPR65 | PKM 2610/4885CYP1A2 1060/4885CYP2D6 2328/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.